-+ 0.00%
-+ 0.00%
-+ 0.00%

UPDATE: Vor Biopharma Q3 Adj. EPS $(3.33) Misses $(3.25) Estimate

Benzinga·11/14/2025 04:27:55
Listen to the news
Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(3.33) per share which missed the analyst consensus estimate of $(3.25) by 2.37 percent. This is a 58.39 percent increase over losses of $(8.00) per share from the same period last year.